BG-102

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameBG-102
Drug Alias NameBG-102BG102
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 2 receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 2 receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSL BIGEN Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSL BIGEN Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A